Literature DB >> 17317424

Antibiotic-resistant organisms in the neonatal intensive care unit.

Matthew J Bizzarro1, Patrick G Gallagher.   

Abstract

Neonates, particularly those born prematurely, are at an increased risk of bacterial infection. Empiric treatment with antimicrobials occurs frequently in the neonatal intensive care unit (NICU). Repeated and/or prolonged courses of antibiotic exposure have resulted in an increase in the prevalence of hospital-acquired, antibiotic-resistant organisms such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and multidrug-resistant Gram-negative rods. As bacterial strains become increasingly resistant to standard antimicrobial therapy, measures to control and prevent this problem are essential. Current efforts have focused on monitoring and restricting the use of antimicrobials, proper hand hygiene, evaluation of potential reservoirs of bacterial acquisition and transmission, cohorting and isolation of colonized infants, decolonization strategies, and fostering of effective inter- and intrahospital communication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317424     DOI: 10.1053/j.semperi.2007.01.004

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  17 in total

1.  Developing clinical decision support within a commercial electronic health record system to improve antimicrobial prescribing in the neonatal ICU.

Authors:  R S Hum; K Cato; B Sheehan; S Patel; J Duchon; P DeLaMora; Y H Ferng; P Graham; D K Vawdrey; J Perlman; E Larson; L Saiman
Journal:  Appl Clin Inform       Date:  2014-04-09       Impact factor: 2.342

Review 2.  Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship.

Authors:  Sameer J Patel; Lisa Saiman
Journal:  Clin Perinatol       Date:  2010-09       Impact factor: 3.430

3.  Analysis of ESBL- and AmpC-positive Enterobacteriaceae at the Department of Neonatology, University Hospital Olomouc.

Authors:  Vendula Husičková; Magdaléna Chromá; Milan Kolář; Kristýna Hricová; Taťána Stosová; Lumír Kantor; Lubomír Dubrava
Journal:  Curr Microbiol       Date:  2011-03-13       Impact factor: 2.188

4.  Neutrophil CD64 as a diagnostic marker in neonatal sepsis.

Authors:  Iris Streimish; Matthew Bizzarro; Veronika Northrup; Chao Wang; Sara Renna; Nancy Koval; Fang-Yong Li; Richard Ehrenkranz; Henry M Rinder; Vineet Bhandari
Journal:  Pediatr Infect Dis J       Date:  2012-07       Impact factor: 2.129

5.  Epidemiological Evaluation of Blood Culture Patterns among Neonates Receiving Vancomycin.

Authors:  Salman Y Yakub; Jonathan E Constance; Chris Stockmann; Matthew Linakis; Sarah C Campbell; Catherine M T Sherwin; Ernest K Korgenski; Alfred Balch; Michael G Spigarelli
Journal:  Indian J Microbiol       Date:  2014-06-17       Impact factor: 2.461

6.  Optimizing the Use of Antibacterial Agents in the Neonatal Period.

Authors:  Joseph B Cantey
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

7.  Intestinal carriage of multidrug-resistant gram-negative bacteria in preterm-infants during hospitalization in neonatal intensive care unit (NICU).

Authors:  Polly Soo Xi Yap; Azanna Ahmad Kamar; Chun Wie Chong; Ivan Kok Seng Yap; Kwai Lin Thong; Yao Mun Choo; Mohd Yasim Md Yusof; Cindy Shuan Ju Teh
Journal:  Pathog Glob Health       Date:  2016-09-21       Impact factor: 2.894

Review 8.  Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit.

Authors:  Melissa U Nelson; Patrick G Gallagher
Journal:  Semin Perinatol       Date:  2012-12       Impact factor: 3.300

9.  Colonization With Antimicrobial-Resistant Gram-Negative Bacilli at Neonatal Intensive Care Unit Discharge.

Authors:  Sarah A Clock; Yu-Hui Ferng; Setareh Tabibi; Luis Alba; Sameer J Patel; Haomiao Jia; Patricia DeLaMora; Jeffrey M Perlman; David A Paul; Theoklis Zaoutis; Elaine L Larson; Lisa Saiman
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

Review 10.  First 1000 Days of Life: Consequences of Antibiotics on Gut Microbiota.

Authors:  Julio Aires
Journal:  Front Microbiol       Date:  2021-05-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.